Alzprotect SAS

Therapeutic Solutions for Neurodegeneration

Add To Watchlist
General Information
Company Name
Alzprotect SAS
Founded Year
2007
Location (Offices)
France +1
Founders / Decision Makers
Laurent Dupire - CEO & General manager Philippe Verwaerde - President and CSO Patricia Melnyk - Co-Founder
Number of Employees
12
Industries
Biotechnology, Pharmaceutical
Funding Stage
Grant
Social Media

Alzprotect SAS - Company Profile

AlzProtect is a biopharmaceutical startup established in 2007, specializing in the development of drug candidates aimed at treating neurodegenerative diseases and rare tauopathies, including Alzheimer's disease and Progressive Supranuclear Palsy (PSP). The company's focus ranges from discovery to clinical trials, with the ultimate goal of providing solutions for these challenging conditions. Their latest funding round of $338.00K came in the form of a grant investment from the Michael J. Fox Foundation on 01 June 2022. With a strong commitment to pioneering drug development in this critical area, AlzProtect is positioned to make meaningful contributions to the field, bolstered by the support of esteemed investors.

Taxonomy: biopharmaceutical company, drug development, neurodegenerative diseases, Alzheimer's disease, tauopathies, rare diseases, clinical trials, neuroscience research, pharmaceutical industry, biotech startups

Funding Rounds & Investors of Alzprotect SAS (5)

View All
Funding Stage Amount No. Investors Investors Date
Grant $338.00K 1
The Michael J. Fox Foundation for Parkinson's Research, investor in Alzprotect SAS's Grant round
01 Jun 2022
Series B €14.00M 1
Xerys Captial, investor in Alzprotect SAS's Series B round
22 Jan 2018
Series A €2.00M 2
Nord France Amorcage, investor in Alzprotect SAS's Series A round Finovam Gestion, investor in Alzprotect SAS's Series A round
11 Jun 2014
Venture Round Unknown 1
FINORPA, investor in Alzprotect SAS's Venture Round round
01 Nov 2008
Non Equity Assistance Unknown 1 Eurasante 13 Feb 2007

Latest News of Alzprotect SAS

View All

No recent news or press coverage available for Alzprotect SAS.

Similar Companies to Alzprotect SAS

View All
Intercept Pharmaceuticals - Similar company to Alzprotect SAS
Intercept Pharmaceuticals Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
Vandria SA - Similar company to Alzprotect SAS
Vandria SA We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases
CENSO BIOTECHNOLOGIES LTD - Similar company to Alzprotect SAS
CENSO BIOTECHNOLOGIES LTD A leading CRO with unparalleled expertise in intricate cell biology, focusing on human neurodegenerative, neuroinflammatory, and inflammatory disease models.
Rubedo Life Sciences - Similar company to Alzprotect SAS
Rubedo Life Sciences Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging
Neuron23 - Similar company to Alzprotect SAS
Neuron23 We are a biotech company focused on developing precision medicines for neurological and immunological diseases.
Circle Decoration Circle Decoration

Want to dive deeper into Alzprotect SAS? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now